Title

CAl25、CAl53、CAl99、β-HCG聯合檢測在乳腺癌病情監測中的意義

Translated Titles

Significance on Evaluation of Extent of Measuring CAl25, CAl53, CAl99, β-HCG for Patients with Breast Cancer

Authors

胡春梅(Chun-Mei Hu);李亞榮(Ya-Rong Li);夏大文(Da-Wen Xia);朱睿(Rui Zhu)

Key Words

乳腺癌 ; CAl25 ; CAl53 ; CAl99 ; β-HCG ; breast cancer ; CAl25 ; CAl53 ; CAl99 β-HCG

PublicationName

激光雜誌

Volume or Term/Year and Month of Publication

26卷6期(2005 / 12 / 01)

Page #

100 - 100

Content Language

簡體中文

Chinese Abstract

目的:探討CA系列β-HCG聯合檢測在乳腺癌病情監測中的意義。方法;利用雙抗體夾心法對84例乳腺癌患者進行CAl25、CAl99、β-HCG的檢測,並觀察其在不同TNM分期及其不同病理水平的變化。TNM臨床分期越晚,4種腫瘤標誌物水平越高;不同病理類型的患者之間4種腫瘤標誌物水平顯著性差異:聯合檢測可提高病情評估的靈敏度。結論;該4種腫瘤標誌物在乳腺癌病情監測方面可為臨床提供有價值的資料。

English Abstract

Objective: To study the clinical significance of carcinoma associated antigen (CAl25, CAl53, CAl99) and human chorionic gonadotropin (β-HCG) in evaluation of disease extent and monitoring metastasis and recurrence of breast cancer. Methods: These tumor markers in serum were measured in 84 patients with breast cancers, and change of the markers were observed in these patients with different stage and pathohistological evidence. Results: The later the stage of TNM of breast cancer, the higher levels of 4 tumor markers would he revealed. There was no significant difference in the levels of 4 tumor markers for patients with different pathohistological evidence. Combination of these tumor markers increased sensitivity of measurement. Conclusions: Measurement of CAl25, CAl53, CAl99 and β-HCG in serum provided useful information for evaluation of disease extent in patients with breast cancer.

Topic Category 基礎與應用科學 > 物理
工程學 > 電機工程